Back to Search
Start Over
Heart failure survival score in patients with Chagas disease: correlation with functional variables.
- Source :
-
Revista espanola de cardiologia (English ed.) [Rev Esp Cardiol (Engl Ed)] 2012 Jun; Vol. 65 (6), pp. 538-43. Date of Electronic Publication: 2012 Apr 16. - Publication Year :
- 2012
-
Abstract
- Introduction and Objectives: Chagas disease is a prevalent cause of heart failure in Latin America, and its prognosis is worse than other etiologies. The Heart Failure Survival Score has been used to assess prognosis in patients with heart failure; however, this score has not yet been studied in patients with Chagas cardiopathy.<br />Methods: The Heart Failure Survival Score was calculated in 55 patients with severe left ventricular systolic dysfunction due to Chagas disease. Correlations were assessed between the Heart Failure Survival Score and variables obtained from, cardiopulmonary exercise tests, quality-of-life measures, and 6-minute walking tests.<br />Results: Patients were distributed among New York Heart Association classes II-IV; 89% were taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, 62% were taking beta-blockers, 86% were taking diuretics, and 74% were taking aldosterone receptor blockers. The mean Heart Failure Survival Score was 8.75 (0.80). The score correlated well with cardiopulmonary test variables such as peak oxygen uptake (0.662; P<.01), oxygen uptake at the anaerobic threshold (0.644; P<.01), ventilation carbon dioxide efficiency slope (-0.417; P<.01), oxygen pulse (0.375; P<.01), oxygen uptake efficiency slope (0.626; P<.01), 6-minute walking test (0.370; P<.01), left ventricle ejection fraction (0.650; P=.01), and left atrium diameter (-0.377; P<.01). There was also a borderline significant correlation between the Heart Failure Survival Score and quality of life (-0.283; P<.05).<br />Conclusions: In heart failure patients with Chagas disease, the Heart Failure Survival Score correlated well with the main prognostic functional test variables.<br /> (Copyright © 2011 Sociedad Española de Cardiología. Published by Elsevier Espana. All rights reserved.)
- Subjects :
- Adrenergic beta-Antagonists therapeutic use
Adult
Aged
Angiotensin Receptor Antagonists therapeutic use
Angiotensin-Converting Enzyme Inhibitors therapeutic use
Chagas Cardiomyopathy complications
Chagas Cardiomyopathy physiopathology
Echocardiography
Exercise Test methods
Female
Heart Failure drug therapy
Heart Failure etiology
Heart Failure physiopathology
Humans
Male
Middle Aged
Quality of Life
Survival Analysis
Ventricular Dysfunction, Left drug therapy
Ventricular Dysfunction, Left etiology
Ventricular Dysfunction, Left physiopathology
Young Adult
Chagas Cardiomyopathy mortality
Heart Failure mortality
Ventricular Dysfunction, Left mortality
Subjects
Details
- Language :
- English
- ISSN :
- 1885-5857
- Volume :
- 65
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Revista espanola de cardiologia (English ed.)
- Publication Type :
- Academic Journal
- Accession number :
- 22513344
- Full Text :
- https://doi.org/10.1016/j.recesp.2011.12.019